A Single-Center Pilot Study to Assess Macular Function

N/ACompletedNCT01204541

ORA, Inc.24 enrolled

Overview

This study seeks to evaluate a novel endpoint for future dry AMD clinical trials.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Macular Degeneration

Eligibility

Sex: ALLMin age: 20 YearsMax age: 90 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Subjects in good health aged 20-29 or 60-90 years (normal cohorts) * Subjects with early non-exudative age-related macular degeneration (AMD cohort) Exclusion Criteria: * Enrollment in a investigational drug or device study and have used an investigational drug or device within 7 days of enrollment into this study

Locations (1)

Unnamed facility

Andover, Massachusetts, United States

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.